S
Stereotaxis Inc (STXS)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX
$0.81
-0.04 (-4.48%)
Market Cap: $85.02M
Last updated: Nov 17, 2026 at 11:05 AM ET
Stereotaxis Inc (STXS) Valuation Multiples
Stereotaxis (STXS) trades at 2.6x sales and 3.9x book value. Its P/S of 2.6x is below its 5-year median of 6.1x. Its forward P/E is 19.6x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 19.6x |
| Price to sales | 2.6x |
| Price to book | 3.9x |
| PEG | N/A |
| FCF yield | -18.8% |
Historical Medians
Against its 10-year medians, its P/S is 53.6% below 5.6x and its P/B is 64.9% below 11.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.6x | 6.1x | 5.6x |
| P/B | 3.9x | 11.1x | 11.1x |
Valuation History
Over the 10 year ends shown, its P/S ranged from 0.4x in 2016 to 110.5x in 2019.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $2.30 | 6.5x | 11.8x |
| 2024 | $2.28 | 7.2x | 17.3x |
| 2023 | $1.75 | 5.3x | 6.6x |
| 2022 | $2.07 | 5.6x | 4.9x |
| 2021 | $6.20 | 13.4x | 11.9x |
| 2020 | $5.09 | 13.9x | 9.5x |
| 2019 | $5.29 | 110.5x | 12.6x |
| 2018 | $1.08 | 1.8x | 8.8x |
| 2017 | $0.80 | 0.6x | N/A |
| 2016 | $0.65 | 0.4x | N/A |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About STXS
What is STXS's forward P/E ratio?
Stereotaxis has a forward P/E ratio of 19.6x.
Is STXS stock overvalued?
GNG's valuation label for STXS is Undervalued.
What is STXS's price to sales ratio?
Stereotaxis has a price to sales ratio of 2.6x.
STXS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors